LIXT
Lixte Biotechnology Holdings IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$24.80M
P/E Ratio
—
EPS
$-1.30
Beta
1.00
52W High
$6.26
52W Low
$0.64
50-Day MA
$3.04
200-Day MA
$3.77
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Lixte Biotechnology Holdings Inc
Lixte Biotechnology Holdings, Inc. is a drug discovery company that uses biomarker technology to identify enzyme targets related to serious common diseases and designs novel compounds to attack those targets. The company is headquartered in East Setauket, New York.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -102.00% |
| Return on Assets | -46.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.90 |
| Price-to-Book | 3.35 |
| Price-to-Sales (TTM) | 20.35 |
| EV/Revenue | 34.5 |
| EV/EBITDA | -1.50 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $8.70M |
| Float | $11.60M |
| % Insiders | 0.46% |
| % Institutions | 7.54% |
Data last updated: 4/8/2026